StonvexLoading…
StonvexStonvexStonvexCore line items from NDAQ's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $8.26B | $7.40B | $6.06B | $6.23B |
Operating Income | $2.33B | $1.80B | $1.58B | $1.56B |
Net Income | $1.79B | $1.12B | $1.06B | $1.13B |
EPS (Diluted) | $3.09 | $1.93 | $2.08 | $2.26 |
Total Assets | $31.05B | $30.39B | $32.29B | $20.87B |
Total Liabilities | $18.82B | $19.20B | $21.47B | $14.70B |
Cash & Equivalents | $604.00M | $592.00M | $453.00M | $502.00M |
Free Cash Flow OCF − CapEx | $1.99B | $1.73B | $1.54B | $1.55B |
Shares Outstanding | 569.89M | 575.06M | 575.00M | 492.00M |